| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/01/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Common Stock | 39.3k | $0.00 | $0 | | 05/01/2023 |
| 05/01/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to Buy) | 55.2k | $2.76 | $152.4k | | 05/01/2023 |
| 04/03/2023 | Zai Lab Ltd | ZLAB | Grant | Stock Options (Right to Buy) | 113.2k | $33.95 | $3.8M | | 04/03/2023 |
| 04/03/2023 | Zai Lab Ltd | ZLAB | Grant | Restricted Share Units | 21.6k | $0.00 | $0 | | 04/03/2023 |
| 12/30/2022 | Zai Lab Ltd | ZLAB | Grant | | 126k | $0.00 | $0 | | 12/30/2022 |
| 12/30/2022 | Zai Lab Ltd | ZLAB | Grant | Stock Options (Right to Buy) | 183.7k | $30.70 | $5.6M | | 12/30/2022 |
| 10/07/2022 | Allogene Therapeutics, Inc. | ALLO | Payment of Exercise | Common Stock | 8.5k | $11.83 | $100.1k | | 10/07/2022 |
| 10/07/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 19.1k | $0.00 | $0 | | 10/07/2022 |
| 10/03/2022 | Allogene Therapeutics, Inc. | ALLO | Payment of Exercise | Common Stock | 9k | $11.06 | $99.2k | | 10/03/2022 |
| 08/02/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 2k | $11.97 | $23.9k | | 08/02/2022 |
| 07/05/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 2k | $11.44 | $22.9k | | 07/05/2022 |
| 06/21/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 2k | $11.18 | $22.4k | | 06/21/2022 |
| 05/19/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 11.5k | $7.40 | $85.1k | | 05/19/2022 |
| 03/23/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 237.4k | $0.00 | $0 | | 03/23/2022 |
| 03/23/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 368.6k | $9.69 | $3.6M | | 03/23/2022 |
| 03/15/2022 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 5.2k | $7.71 | $39.8k | | 03/15/2022 |
| 10/01/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 11.5k | $24.35 | $280.2k | | 10/01/2021 |
| 05/18/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 200.5k | $0.00 | $0 | | 05/18/2021 |
| 03/26/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 92.4k | $33.78 | $3.1M | | 03/26/2021 |
| 03/26/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 24.9k | $0.00 | $0 | | 03/26/2021 |
| 03/15/2021 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 2.8k | $38.05 | $106.5k | | 03/15/2021 |
| 10/07/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 16.5k | $39.40 | $651.5k | | 10/07/2020 |
| 10/01/2020 | Allogene Therapeutics, Inc. | ALLO | Sale | Common Stock | 9.8k | $36.37 | $354.7k | | 10/01/2020 |
| 03/18/2020 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 30.8k | $0.00 | $0 | | 03/18/2020 |
| 03/18/2020 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 109.6k | $18.22 | $2M | | 03/18/2020 |
| 09/03/2019 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 105.2k | $0.00 | $0 | | 09/03/2019 |
| 09/03/2019 | Allogene Therapeutics, Inc. | ALLO | Grant | Stock Option (Right to Buy) | 160.6k | $26.15 | $4.2M | | 09/03/2019 |
| 08/06/2019 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 11k | $2.06 | $22.7k | | 08/06/2019 |
| 01/14/2019 | Adaptimmune Therapeutics PLC | ADAP | Sale | | 3k | $5.37 | $16.3k | | 01/14/2019 |
| 01/04/2019 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 224.7k | $0.00 | $0 | | 01/04/2019 |
| 01/04/2019 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 1M | $0.00 | $0 | | 01/04/2019 |
| 08/06/2018 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 678.7k | $0.00 | $0 | | 08/06/2018 |
| 01/12/2018 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 192.1k | $0.00 | $0 | | 01/12/2018 |
| 01/12/2018 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 860k | $0.00 | $0 | | 01/12/2018 |
| 01/13/2017 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 2.1M | $0.00 | $0 | | 01/13/2017 |